Risk Factor Reduction

FDA Approved Medications

Alendronate sodium (Fosamax)

Calcitonin-salmon (Miacalcin)

Estrogen Therapy / Hormone Therapy

Ibandronate sodium (Boniva)

Risedronate sodium (Actonel)

Raloxifene hydrochloride (Evista)

Teriparatide (Forteo)

Zoledronic acid (Reclast)

Other Treatments

Ibandronate (Boniva)

Prevention and treatment of osteoporosis should always include a nutrient-rich diet, the recommended intake of calcium and vitamin D, regular physical activity, safety precautions for fall prevention, avoidance of smoking and limited consumption of alcohol. If osteoporosis is diagnosed, you still must continue to make bone healthy lifestyle choices. However, lifestyle modifications alone are often not enough. Your healthcare provider may prescribe an osteoporosis medication to help stop further bone loss and reduce your risk for broken bones.

What are the medication options for osteoporosis?

The U.S. Food and Drug Administration (FDA) has approved several medications for osteoporosis which fall into two classes: antiresorptive medications and anabolic medications. Antiresorptive medications are used to strengthen bone, prevent bone loss and reduce the risk of fracture (broken bone).

The antiresorptive medications include a class of drugs called bisphosphonates.The four bisphosphonate medications are:

  • alendronate - available as a generic medication (Brand name: Fosamax, Fosamax D)
  • risedronate (Brand name: Actonel, Actonel with Calcium )
  • ibandronate ( Brand name: Boniva)
  • zoledronic acid (Brand name: Reclast)

Other approved antiresorptive medications include:

Anabolic medication builds new bone, increases bone density and helps reduce fracture risk. At this time the only approved anabolic medication is:

It is important to speak to your healthcare provider about the medication option that is right for you.

What is ibandronate (Boniva)?


Ibandronate sodium is the generic name for Boniva (brand name). It is a bisphosphonate medication. Ibandronate is not a hormone. It works only on the bone and does not affect the heart, breast, uterus or other parts of the body.

What is the approved use for ibandronate?

Ibandronate is FDA-approved for the prevention and treatment of osteoporosis in postmenopausal women.


How is ibandronate (Boniva) usually prescribed?

The FDA has approved ibandronate as a 150mg tablet taken once a month or a 3mg injection given once every 3 months. When taking ibandronate, it is recommended to get adequate calcium and vitamin D each day. It also important to follow the universal strategies for promotion of healthy bones.


What are the benefits of ibandronate?

Clinical studies indicate that ibandronate increases bone mineral density (BMD) of the existing skeleton and reduces the risk of spine fractures in postmenopausal women with osteoporosis. In postmenopausal women with very severe osteoporosis, ibandronate reduces the risk of fractures throughout the skeleton. Like all medications, it is important to discuss all of the potential benefits and risks of taking this medication with your healthcare provider.


What are the side effects of taking ibandronate?

The side effects of oral ibandronate may include upset stomach (dyspepsia), pain in the extremities (arms or legs) and diarrhea. Ibandronate  tablets may also cause ulcers in the stomach or esophagus (the tube that connects your mouth and stomach), heartburn (esophagitis), or difficult/painful swallowing (dysphagia). Heartburn and irritation of the esophagus but can usually be avoided by taking the medication properly. ibandronate tablets must be taken first thing in the morning on an empty stomach with at least 1 cup (240 ml or 8 ounces) of plain (tap) water. Do not take ibandronate with any other beverages such as mineral water, juice, milk, coffee or tea. After taking this medication, you must remain upright (in a sitting or standing position) and avoid bending over or lying down for at least 60 minutes.

Injectable ibandronate does not have effect the esophagus or stomach and there are no special instructions regarding eating, drinking, or positioning following its use. Ibandronate sodium taken orally or by injection have the potential adverse effect of flu-like symptoms that may last for a few days after taking the medication.

Rarely, dental complications occur when taking bisphosphonate medications,mostly in high-risk patients. It is important to see your dentist for a complete oral examination before taking ibandronate. During treatment with a bisphosphonate medication, it is vital to practice good oral hygiene and to continue to see your dentist for regular checkups.and rarely, dental complications that occur mostly in high risk patients. 

Like all medications, it is important to discuss all of the potential benefits and risks of taking this medication with your healthcare provider. For more information about ibandronate (Boniva), visit the Roche Therapeutics, Inc. website.






Home | About Us | Contact Us | In Your RegionSupport Groups
 In the News  | FAQSearch | Acknowledgements | Site Index
About Osteoporosis | Causes | ConsequencesPrevention
  Diagnosis | Treatment | WomenMen  | Children & Teens

The advice or information contained on these pages should NOT be construed as medical advice. Consult with your doctor or health care provider about your individual needs related to the prevention, diagnosis and treatment of osteoporosis.

© 2004-2009 NYSOPEP